Back to Search Start Over

Chemokine receptor antagonist block inflammation and therapy Japanese encephalitis virus infection in mouse model.

Authors :
Liu, Ke
Xiao, Changguang
Wang, Feifei
Xiang, Xiao
Ou, Anni
Wei, Jianchao
Li, Beibei
Shao, Donghua
Miao, Denian
Zhao, Fanfan
Long, Gang
Qiu, Yafeng
Zhu, Huaimin
Ma, Zhiyong
Source :
Cytokine. Oct2018, Vol. 110, p70-77. 8p.
Publication Year :
2018

Abstract

Japanese encephalitis (JE) is a viral encephalitis disease caused by infection with the Japanese encephalitis virus (JEV). The virus can cross the blood-brain barrier and cause death or long-term sequela in infected humans or animals. In this study, we first investigated the distribution of JEV infection in brain and further analyzed the dynamic change in inflammation related genes, chemokines, as well as pathological characteristics. Results demonstrated that CCR2 and CCR5 antagonist could significantly inhibit the inflammation. The mice treated with CCR2 and CCR5 antagonists had a higher survival rate between 60% and 70%, respectively. In summary, our study thoroughly illustrated the characteristics of the dynamic change in inflammation related genes and chemokines induced by JEV infection. We further indicated that CCR5 and CCR2 are potential targets for treatment of JE. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10434666
Volume :
110
Database :
Academic Search Index
Journal :
Cytokine
Publication Type :
Academic Journal
Accession number :
131295884
Full Text :
https://doi.org/10.1016/j.cyto.2018.04.022